Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 1

Relationship Between Endocrinopathies andFerritin Levels in Adult Turkish Patients with BetaThalassemia Major: A Single-Center Experience

Pages
37–42
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For the analysis, we used an independent samples t-test when parametric testassumptions were met; otherwise we used Mann–Whitney U test.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Despite regular transfusions and iron-chelation therapies, endocrine complications still remain an importantcause of morbidity in patients with beta thalassemia major (BTM).
📊
Key Findings & Data:We aimed to evaluate the relationship between endocrinecomplications and serum ferritin levels in adult patients with BTM.
💡
Conclusion & Impact:For the analysis, we used an independent samples t-test when parametric testassumptions were met; otherwise we used Mann–Whitney U test.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Despite regular transfusions and iron-chelation therapies, endocrine complications still remain an importantcause of morbidity in patients with beta thalassemia major (BTM). We aimed to evaluate the relationship between endocrinecomplications and serum ferritin levels in adult patients with BTM. Materials and Methods: The endocrine test results of adult patients with BTM were retrospectively reviewed. Normality test ing was performed using the Shapiro–Wilk test. For the analysis, we used an independent samples t-test when parametric testassumptions were met; otherwise we used Mann–Whitney U test. A p value of

🔖

Cite This Article

ÇAĞLIYAN, G. A., SOYER, N., HACIOĞLU, S., GÜLER, N., YAYLALI, G. F., ÇAĞLIYAN, Ö. (2022). Relationship Between Endocrinopathies andFerritin Levels in Adult Turkish Patients with BetaThalassemia Major: A Single-Center Experience. Erciyes Medical Journal, Cilt: 43 - Sayı: 1, 37–42. https://ajindex.com/articles/502214

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bordbar M, Bozorgi H, Saki F, Haghpanah S, Karimi M, Bazrafshan A, et al. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran. J Endocrinol Invest 2019; 42(12):1467–76
  2. Yaghobi M, Miri-Moghaddam E, Majid N, Bazi A, Navidian A, Kalkali A. Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran. Int J Hematol Oncol Stem Cell Res 2017; 11(4): 268–72
  3. He LN, Chen W, Yang Y, Xie YJ, Xiong ZY, Chen DY, et al. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis. Biomed Res Int 2019; 2019: 6573497
  4. Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, et al. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol 2015; 94(5): 404–12
  5. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC; Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006; 19(4): 471–80
  6. Varma N, Sharma P. Controversies in Pediatric and Adolescent Hematology. Indian J Med Res 2015; 141(6): 848–9
  7. Soliman AT, Yassin MA, De Sanctis V. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC. Acta Biomed 2018; 89(2-S): 27–32
  8. Di Maggio R, Maggio A. The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major. Br J Haematol 2017; 178(5): 676–88
  9. Dejkhamron P, Wejaphikul K, Mahatumarat T, Silvilairat S, Charoenkwan P, Saekho S, et al. Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital. Pediatr Hematol Oncol 2018; 35(1): 52–9
  10. Nasir C, Rosdiana N, Lubis AD. Correlation between 25-Hydroxyvitamin D and Lipid Profile among Children with Beta Thalassemia Major. Open Access Maced J Med Sci 2018; 6(10): 1790–4
  11. Fahim FM, Saad K, Askar EA, Eldin EN, Thabet AF. Growth Parameters and Vitamin D status in Chil